Trial · NCT00843024
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Single-blind Placebo Run-In Phase | STARTED | 12 to 14 Years Age Group: Single-blind Phase | 408 | |
| Single-blind Placebo Run-In Phase | STARTED | 15 to 17 Years Age Group: Single-blind Phase | 457 | |
| Single-blind Placebo Run-In Phase | STARTED | Placebo | 0 | |
| Single-blind Placebo Run-In Phase | STARTED | Sumatriptan 10 mg/ Naproxen 60 mg | 0 | |
| Single-blind Placebo Run-In Phase | STARTED | Sumatriptan 30 mg/ Naproxen 180 mg | 0 | |
| Single-blind Placebo Run-In Phase | STARTED | Sumatriptan 85 mg/ Naproxen 500 mg | 0 | |
| Single-blind Placebo Run-In Phase | COMPLETED | 12 to 14 Years Age Group: Single-blind Phase | 268 | |
| Single-blind Placebo Run-In Phase | COMPLETED | 15 to 17 Years Age Group: Single-blind Phase | 321 | |
| Single-blind Placebo Run-In Phase | COMPLETED | Placebo | 0 | |
| Single-blind Placebo Run-In Phase | COMPLETED | Sumatriptan 10 mg/ Naproxen 60 mg | 0 | |
| Single-blind Placebo Run-In Phase | COMPLETED | Sumatriptan 30 mg/ Naproxen 180 mg | 0 | |
| Single-blind Placebo Run-In Phase | COMPLETED | Sumatriptan 85 mg/ Naproxen 500 mg | 0 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | 12 to 14 Years Age Group: Single-blind Phase | 140 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | 15 to 17 Years Age Group: Single-blind Phase | 136 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | Placebo | 0 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | Sumatriptan 10 mg/ Naproxen 60 mg | 0 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | Sumatriptan 30 mg/ Naproxen 180 mg | 0 | |
| Single-blind Placebo Run-In Phase | NOT COMPLETED | Sumatriptan 85 mg/ Naproxen 500 mg | 0 | |
| Double-blind Treatment Phase | STARTED | 12 to 14 Years Age Group: Single-blind Phase | 0 | |
| Double-blind Treatment Phase | STARTED | 15 to 17 Years Age Group: Single-blind Phase | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00843024/flow